Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Cancer Immunology Research|November 12, 2020
Improved T-cell Receptor Diversity Estimates Associate with Survival and Response to Anti-PD-1 TherapyDante S Bortone, Mark G Woodcock, Joel S Parker, et al.
Frontiers in Oncology|July 14, 2026
Case Report: A case series on actionable genomic alterations guiding effective targeted therapy in rare sarcomasJamie L Zeal, Mark G Woodcock, Kevin Y Chen, et al.
Journal for Immunotherapy of Cancer|March 7, 2023
Evaluation of tumor antigen-specific antibody responses in patients with metastatic triple negative breast cancer treated with cyclophosphamide and pembrolizumabEric D Routh, Mark G Woodcock, Wolfgang Beckabir, et al.
The Journal of Clinical Investigation|January 6, 2022
Rapid idiosyncratic mechanisms of clinical resistance to KRAS G12C inhibitionYihsuan S Tsai, Mark G Woodcock, Salma H Azam, et al.
The Journal of Clinical Investigation|October 28, 2025
Molecular glue degrader function of SPOP inhibitors enhances STING-dependent immunotherapy efficacy in melanoma modelsZhichuan Zhu, Xin Zhou, Max Xu, et al.
Blood Advances|July 21, 2025
A Simple and Efficient Method for the Robust Expansion of Human ILC2s to Prevent Acute GvHDDanny W Bruce, Sonia J Laurie, Yan Xing, et al.
Frontiers in Medicine|June 18, 2026
Differentiating naturally occurring and disease associated autoantibodies in MPO-ANCA vasculitis through immunogenomic and epitope comparisonsDhruti P Chen, Young-Hyun Moon, Bridget A Peck, et al.
Cellular & Molecular Immunology|June 27, 2024
4-1BB-encoding CAR causes cell death via sequestration of the ubiquitin-modifying enzyme A20Zhangqi Dou, Thomas Raphael Bonacci, Peishun Shou, et al.
Nature Communications|January 3, 2024
IL-12 reprograms CAR-expressing natural killer T cells to long-lived Th1-polarized cells with potent antitumor activityElisa Landoni, Mark G Woodcock, Gabriel Barragan, et al.
Nature Cancer|October 1, 2024
CAR-redirected natural killer T cells demonstrate superior antitumor activity to CAR-T cells through multimodal CD1d-dependent mechanismsXin Zhou, Ying Wang, Zhangqi Dou, et al.
Pageof 2